Noticeably, those sEV-RNAs were not necessarily originated from cancer cells, since target-selecting procedures, such as anti-EpCAM-based immuno-capture (Dorayappan et al., 2019; Ostenfeld et al., 2016; Zhang et al., 2019), were not conducted before sEVs isolation. Here, EPCAM is linked to cancer.